S R Friedman

Summary

Affiliation: National Development and Research Institutes
Country: USA

Publications

  1. ncbi Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation
    S R Friedman
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, NY 10048, USA
    Am J Epidemiol 152:913-22. 2000
  2. ncbi Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence
    S R Friedman
    National Development and Research Institutes, Inc, Two World Trade Center, 16th Fl, New York, NY 10048, USA
    Am J Public Health 91:791-3. 2001
  3. ncbi Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996
    S R Friedman
    National Development and Research Institutes, Inc, New York, New York 10048, USA
    J Acquir Immune Defic Syndr 22:83-91. 1999
  4. ncbi Drug scene roles and HIV risk
    S R Friedman
    National Development and Research Institutes, Inc, New York 10048, USA
    Addiction 93:1403-16. 1998
  5. ncbi Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood
    P L Flom
    National Development and Research Institutes, New York, New York 10048, USA
    Sex Transm Dis 28:598-607. 2001
  6. ncbi Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood
    S R Friedman
    National Development Research Institutes, Inc, New York, NY, USA
    AIDS 15:2057-60. 2001
  7. ncbi Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996
    D C Des Jarlais
    Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Public Health 88:1801-6. 1998
  8. ncbi Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997
    C Des Jarlais
    Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA
    Am J Public Health 90:1112-6. 2000
  9. ncbi Consistent condom use in the heterosexual relationships of young adults who live in a high-HIV-risk neighbourhood and do not use "hard drugs"
    S R Friedman
    National Development and Research Institutes, Inc, New York 10048, USA
    AIDS Care 13:285-96. 2001
  10. ncbi Gender differences in injection risk behaviors at the first injection episode
    Vera Frajzyngier
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York City, NY 11215, USA
    Drug Alcohol Depend 89:145-52. 2007

Research Grants

  1. Staying Safe: Long-Term Injection Drug Users Who Have Avoided HIV & Hepatitis C
    Samuel Friedman; Fiscal Year: 2007
  2. COMMUNITY VULNERABILITY AND RESPONSES TO IDU-RELATED HIV
    Samuel Friedman; Fiscal Year: 2007
  3. Community Vulnerability and Responses to Drug-User-Related HIV/AIDS
    Samuel Friedman; Fiscal Year: 2009
  4. LOCAL CONTEXT, SOCIAL-CONTROL ACTION, AND HIV RISK
    Samuel Friedman; Fiscal Year: 2001
  5. COMMUNITY VULNERABILITY AND RESPONSES TO IDU-RELATED HIV
    Samuel Friedman; Fiscal Year: 2003
  6. Community Vulnerability and Responses to Drug-User-Related HIV/AIDS
    Samuel R Friedman; Fiscal Year: 2010

Detail Information

Publications80

  1. ncbi Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation
    S R Friedman
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, NY 10048, USA
    Am J Epidemiol 152:913-22. 2000
    ..Thus, in situations of declining prevalence, prevention programs should be maintained or strengthened...
  2. ncbi Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence
    S R Friedman
    National Development and Research Institutes, Inc, Two World Trade Center, 16th Fl, New York, NY 10048, USA
    Am J Public Health 91:791-3. 2001
    ..This study sought to assess relations of laws prohibiting over-the-counter syringe sales (anti-OTC laws) to population prevalence of injection drug users and HIV prevalence or incidence among 96 US metropolitan areas...
  3. ncbi Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996
    S R Friedman
    National Development and Research Institutes, Inc, New York, New York 10048, USA
    J Acquir Immune Defic Syndr 22:83-91. 1999
    ..To measure differences and similarities in the prevalence of HIV infection and of related risk and protective behaviors among New York City black, white, and Hispanic drug injectors during a period of decreasing HIV prevalence...
  4. ncbi Drug scene roles and HIV risk
    S R Friedman
    National Development and Research Institutes, Inc, New York 10048, USA
    Addiction 93:1403-16. 1998
    ..This paper aims to measure "role behaviors" of drug injectors; describe which drug injectors are more likely to engage in such role behaviors; and to determine whether roles are related to elements of HIV risk...
  5. ncbi Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood
    P L Flom
    National Development and Research Institutes, New York, New York 10048, USA
    Sex Transm Dis 28:598-607. 2001
    ..Sex risks and drug use are related. This relation in youth is described...
  6. ncbi Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood
    S R Friedman
    National Development Research Institutes, Inc, New York, NY, USA
    AIDS 15:2057-60. 2001
    ..Having ever had anal sex was associated with having ever been infected with hepatitis B...
  7. ncbi Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996
    D C Des Jarlais
    Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Public Health 88:1801-6. 1998
    ..This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City...
  8. ncbi Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997
    C Des Jarlais
    Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA
    Am J Public Health 90:1112-6. 2000
    ..This study assessed trends in HIV risk behaviors among injection drug users in New York City from 1990 to 1997...
  9. ncbi Consistent condom use in the heterosexual relationships of young adults who live in a high-HIV-risk neighbourhood and do not use "hard drugs"
    S R Friedman
    National Development and Research Institutes, Inc, New York 10048, USA
    AIDS Care 13:285-96. 2001
    ..Programmes to increase condom use among young adults should focus on strengthening norms that promote safer sex to protect oneself and others. In addition, assistance should be provided to youth who are problem drinkers...
  10. ncbi Gender differences in injection risk behaviors at the first injection episode
    Vera Frajzyngier
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York City, NY 11215, USA
    Drug Alcohol Depend 89:145-52. 2007
    ..To examine gender differences in drug injection equipment sharing at injecting initiation...
  11. ncbi Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors
    A Neaigus
    National Development and Research Institutes, Inc, New York City, NY, USA
    Addiction 96:847-60. 2001
    ..To compare potential risk factors for the transition to injecting among non-injecting heroin users (NIUs) with different injecting histories...
  12. ncbi Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus
    A Neaigus
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10048, USA
    J Infect Dis 184:359-63. 2001
    ..HIV-infected NIUs, particularly never IDUs, and, possibly, HCV-infected NIUs, are a potential sexual transmission bridge...
  13. ncbi Relative prevalence of different sexually transmitted infections in HIV-discordant sexual partnerships: data from a risk network study in a high-risk New York neighbourhood
    S R Friedman
    National Development and Research Institutes, Inc, 71 W 23rd Street, 8th Floor, New York, NY 10010, USA
    Sex Transm Infect 84:17-8. 2008
    ..To determine infection patterns of sexually transmitted infections that facilitate HIV transmission among HIV-discordant couples...
  14. ncbi Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Epidemiol 157:467-71. 2003
    ..0/100 person-years) at the Lower East Side site. Results show that high rates of HBV and HCV transmission do not imply high rates of HIV transmission, even within an area of high HIV seroprevalence...
  15. ncbi Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    AIDS 19:S20-5. 2005
    ..The 1990-2001 time period included a very large expansion of syringe exchange in New York City, from 250,000 to 3,000,000 syringes exchanged annually...
  16. ncbi Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents
    P Mateu-Gelabert
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    AIDS Care 17:802-13. 2005
    ..We describe some potential negative consequences of these beliefs and interactions, including their effects on risk for HIV and other sexually transmitted diseases...
  17. ncbi Continued risky injection subsequent to syringe exchange use among injection drug users in New York City
    D Paone
    Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA
    AIDS Educ Prev 9:505-10. 1997
    ..We present other predictors of continued risk and discuss the implications for interventions and make recommendations for syringe exchange programs...
  18. ncbi Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users
    Benny J Kottiri
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, New York, USA
    J Acquir Immune Defic Syndr 30:95-104. 2002
    ..In Bushwick, racially/ethnically discordant risk partnerships involving black IDUs may function as potential bridges of transmission between groups...
  19. ncbi "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001
    Don C Des Jarlais
    Beth Israel Medical Center and dagger National Development and Research Institutes, Inc, New York, NY, USA
    J Acquir Immune Defic Syndr 35:158-66. 2004
    ..To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world...
  20. ncbi HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services
    Don C Des Jarlais
    Beth Israel Medical Center, 1st Ave and 16th St, New York, NY 10003, USA
    Am J Public Health 95:1439-44. 2005
    ..Syringe exchange increased greatly during this period, from 250,000 to 3,000,000 syringes exchanged annually...
  21. ncbi The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY 10038, USA
    Addiction 102:778-85. 2007
    ..To characterize heroin and cocaine users in New York City who have changed from injection to non-injection drug administration and to identify factors associated with long-term non-injection use...
  22. ncbi Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    AIDS 21:231-5. 2007
    ..As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users...
  23. ncbi Consistent condom use among drug-using youth in a high HIV-risk neighbourhood
    S R Friedman
    National Development Research Institutes, Inc, New York, NY 10010, USA
    AIDS Care 14:493-507. 2002
    ..These changes should include changes in gender roles and power relations...
  24. ncbi Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?
    Russell Rockwell
    National Development and Research Institutes, Inc, New York, New York, USA
    J Urban Health 79:136-46. 2002
    ..Enhancing access to services for IDUs in the boroughs outside Manhattan may be needed to continue the positive trends in all areas of New York City...
  25. ncbi Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, 160 Water St 24th Fl, New York, NY 10038, USA
    Am J Public Health 99:S445-51. 2009
    ..We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City...
  26. ncbi Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23d Street, 8th Floor, New York, NY 10010, USA
    BMC Public Health 8:94. 2008
    ..Prevalence rates for long-term injection drug users in some localities surpass 60% for HIV and 80% for HCV. We describe methods for developing grounded hypotheses about how some injectors avoid infection with either virus...
  27. ncbi Syringe exchange, injecting and intranasal drug use
    Don C Des Jarlais
    Beth Israel Medical Center, New York, New York 10038, USA
    Addiction 105:155-8. 2010
    ..The belief that implementation of syringe exchange will lead to increased drug injecting has been a persistent argument against syringe exchange...
  28. ncbi Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs
    Theresa E Perlis
    National Development and Research Institutes, Inc, New York, NY 10003, USA
    Addiction 99:885-96. 2004
    ..A-CASI has been found to increase reporting of sensitive items among a variety of population subgroups...
  29. ncbi Structural and social contexts of HIV risk Among African Americans
    Samuel R Friedman
    Center for Drug Use and HIV Research, National Development and Research Institutes, New York, NY, USA
    Am J Public Health 99:1002-8. 2009
    ..Finally, we conclude with a discussion of how these perspectives might help reduce HIV transmission among African Americans...
  30. ncbi How can hepatitis C be prevented in the long term?
    Pedro Mateu-Gelabert
    Center for Drug Use and HIV Research, National Development Research Institutes, New York City, NY, United States
    Int J Drug Policy 18:338-40. 2007
    ..These studies aim to provide the conceptual basis for developing a new generation of HCV prevention programs to assist both new and experienced IDUs to remain uninfected over the long run...
  31. ncbi Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas
    Barbara Tempalski
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Fl, New York, NY 10010, USA
    Subst Abuse Treat Prev Policy 5:23. 2010
    ..Yet, little is known about changes in drug treatment availability for IDUs in the U.S. This paper investigates change in drug treatment coverage for IDUs in 90 metropolitan statistical areas (MSAs) during 1993-2002...
  32. ncbi Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups
    Samuel R Friedman
    National Development and Research Institutes, Inc, New York, NY, United States
    Int J Drug Policy 18:107-17. 2007
    ..Finally, both researchers and policy makers should help develop ways to enable and support both micro-social and formally organized action by users...
  33. ncbi Exploring an HIV paradox: an ethnography of sexual minority women injectors
    Rebecca M Young
    Barnard College, Department of Women s Studies, New York, NY 10027, USA
    J Lesbian Stud 9:103-16. 2005
    ..However, multiple marginalization was found to be pervasive and to have severe consequences that can be traced to increased HIV risk for many women in the study...
  34. ncbi Social capital or networks, negotiations, and norms? A neighborhood case study
    Samuel R Friedman
    National Development and Research Institutes, Inc, New York, New York 10010, USA
    Am J Prev Med 32:S160-70. 2007
    ....
  35. ncbi Drug arrests and injection drug deterrence
    Samuel R Friedman
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    Am J Public Health 101:344-9. 2011
    ..We tested the hypothesis that higher rates of previous hard drug-related arrests predict lower rates of injection drug use...
  36. ncbi Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Infect Dis 195:1052-61. 2007
    ..Many heroin users do not inject drugs but may still be at risk of infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV), via sexual or other noninjection-related activity...
  37. ncbi Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes Inc, 71 West 23rd Street, New York City, NY 10010, USA
    Drug Alcohol Depend 89:234-43. 2007
    ..Early interventions, targeting injecting and sexual risks and including HBV vaccination, are needed among new IDUs to prevent HBV, HCV and, potentially, HIV epidemics...
  38. ncbi Symbiotic goals and the prevention of blood-borne viruses among injection drug users
    Samuel R Friedman
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, New York 10010, USA
    Subst Use Misuse 46:307-15. 2011
    ..These hypotheses should be tested using cohort studies and prevention trials to see if helping IDUs attain symbiotic goals reduces infection risk. The study's limitations are noted...
  39. ncbi Group sex events amongst non-gay drug users: an understudied risk environment
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23d Street, New York, NY 10010, USA
    Int J Drug Policy 22:1-8. 2011
    ..Such interventions are needed and should be developed...
  40. ncbi Herpes simplex virus-2 and HIV among noninjecting drug users in New York city
    Don C Des Jarlais
    Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10038, USA
    Sex Transm Dis 34:923-7. 2007
    ..To examine the relationship between herpes simplex virus 2 (HSV-2) seroprevalence and human immunodeficiency virus (HIV) seroprevalence among noninjecting heroin and cocaine users in New York City...
  41. ncbi Group sex events and HIV/STI risk in an urban network
    Samuel R Friedman
    National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 49:440-6. 2008
    ..To describe: (a) the prevalence and individual and network characteristics of group sex events (GSEs) and GSE attendees; and (b) HIV/sexually transmitted infection (STI) discordance among respondents who said they went to a GSE together...
  42. ncbi Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    Int J Drug Policy 20:283-91. 2009
    ....
  43. ncbi HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002
    Barbara Tempalski
    National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 86:132-54. 2009
    ..These results warrant further research into the population dynamics of disease progression, access to health services, and the effects of HIV prevention interventions for IDUs...
  44. ncbi For the common good: measuring residents' efforts to protect their community from drug- and sex-related harm
    Pedro Mateu-Gelabert
    NDRI, Inc, New York, USA
    SAHARA J 5:144-57. 2008
    ..It can benefit public health practitioners by helping them understand the environments in which they are intervening and by helping them find ways to cooperate with local neighbourhood-level health activists...
  45. ncbi Social and behavioral correlates of sexually transmitted infection- and HIV-discordant sexual partnerships in Bushwick, Brooklyn, New York
    Maria R Khan
    National Development and Research Institutes, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 51:470-85. 2009
    ..Additional social and behavioral variables may be useful for identifying priority populations...
  46. ncbi Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002
    Joanne E Brady
    Institute for AIDS Research, National Development and Research Institutes, Inc NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 85:323-51. 2008
    ....
  47. ncbi Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 85:309-22. 2008
    ..Legalizing and rapidly implementing sterile syringe distribution programs are critical for reducing parenterally transmitted HIV, HBV, and HCV among IDUs...
  48. ncbi Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug
    Barbara Tempalski
    National Development and Research Institutes, Inc, New York, NY, USA
    Int J Drug Policy 19:S47-58. 2008
    ..Notably, we know little about variations in syringe coverage within the U.S. and elsewhere, or about the social and political factors that might determine this coverage...
  49. ncbi Strategies to avoid opiate withdrawal: implications for HCV and HIV risks
    Pedro Mateu-Gelabert
    National Development Research Institutes, Inc, New York, NY 10010, United States
    Int J Drug Policy 21:179-85. 2010
    ..However, there is little scientific knowledge on how heroin withdrawal affects injection behaviour. This paper explores how withdrawal episodes heighten unsafe injection practices and how some long-term injectors manage such risks...
  50. ncbi Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    Int J Drug Policy 18:475-85. 2007
    ..Here, we determine which metropolitan area characteristics are associated with drug treatment coverage...
  51. ncbi Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users
    Samuel R Friedman
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Urban Health 81:377-400. 2004
    ..Although service provision levels varied considerably, few if any metropolitan areas seemed to be providing adequate levels of services...
  52. ncbi Racial/ethnic disparities in injection drug use in large US metropolitan areas
    Hannah Cooper
    Medical and Health Research Association of New York City, Inc, NY, USA
    Ann Epidemiol 15:326-34. 2005
    ....
  53. ncbi Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamón, Puerto Rico
    Samuel R Friedman
    National Development and Research Institutes, New York, New York 10010, USA
    J Psychoactive Drugs 34:363-9. 2002
    ..Although further research is needed, drug-scene role-holders should be targeted for interventions to affect their own risk and their communications with others...
  54. ncbi HIV among injection drug users in large US metropolitan areas, 1998
    Samuel R Friedman
    Institute for AIDS Research, National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 82:434-45. 2005
    ....
  55. ncbi Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users
    V Anna Gyarmathy
    National Development and Research Institutes, Inc, New York City, New York 10010, USA
    J Acquir Immune Defic Syndr 30:448-56. 2002
    ..To examine lifetime correlates of HIV and hepatitis B and C (HBV and HCV) infections among noninjecting heroin users (NIUs)...
  56. ncbi HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women
    Samuel R Friedman
    National Development and Research Institutes Inc, New York, NY 10010, USA
    Am J Public Health 93:902-6. 2003
  57. ncbi Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas
    Barbara Tempalski
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
    Am J Public Health 97:437-47. 2007
    ..Need was not a predictor...
  58. ncbi Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    AIDS 20:93-9. 2006
    ..To understand associations of punitive policies to the population prevalence of injection drug users and to HIV seroprevalence among injectors...
  59. ncbi Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999
    Carey B Maslow
    National Development and Research Institutes, Inc, 71 West 23rd Street, New York, NY 10010, USA
    Am J Public Health 92:382-4. 2002
    ..This study examined HIV prevalence and risk behaviors among male injection drug users (IDUs) who have sex with men and among other male IDUs...
  60. ncbi Urging others to be healthy: "intravention" by injection drug users as a community prevention goal
    Samuel R Friedman
    AIDS Educ Prev 16:250-63. 2004
    ....
  61. ncbi Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility
    Alan Neaigus
    Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 41:493-503. 2006
    ..To determine the incidence/predictors of transitions to injecting among noninjecting heroin users (NIUs)...
  62. ncbi New York City injection drug users' memories of syringe-sharing patterns and changes during the peak of the HIV/AIDS epidemic
    Russell Rockwell
    National Development and Research Institutes Inc, New York, New York 10010, USA
    AIDS Behav 10:691-8. 2006
    ..IDUs remember when they first became aware of AIDS and began to adjust their behaviors and social assumptions...
  63. ncbi Diffusion of the D.A.R.E and syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    Am J Public Health 96:1354-8. 2006
    ..The decision theory concepts of framing and loss aversion may be useful for further research on the diffusion of public health innovations...
  64. ncbi Some data-driven reflections on priorities in AIDS network research
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    AIDS Behav 11:641-51. 2007
    ....
  65. ncbi Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas
    Hannah L F Cooper
    Medical and Health Research Association of New York City, Inc, New York, NY, USA
    Am J Public Health 97:344-52. 2007
    ..We analyzed the relations of two 1990 dimensions of racial residential segregation (isolation and concentration) with 1998 injection drug use prevalence among Black adult residents of 93 large US metropolitan statistical areas (MSAs)...
  66. ncbi Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City
    Samuel R Friedman
    National Development and Research Institutes, Inc, 71 West 23rd Street, New York, NY 10010, USA
    Addiction 98:159-69. 2003
    ..Drug users, particularly injection drug users and crack smokers, may be a core group for some sexually transmitted infections...
  67. ncbi Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done
    D C Des Jarlais
    Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA
    Public Health Rep 113:182-8. 1998
    ..This chapter reviews the history of research on implementation of programs for prevention of HIV infection among IDUs...
  68. ncbi Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis
    Hannah L F Cooper
    National Development and Research Institutes, New York, NY, USA
    Clin Infect Dis 45:1200-3. 2007
    ..e., injection drug users) remained stable. Increasing methamphetamine use and/or drug injection frequency may have increased the incidence of infective endocarditis among active injection drug users...
  69. ncbi Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts
    Catherine A Hankins
    AIDS 16:2245-52. 2002
  70. ncbi An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men
    Spencer Lieb
    Florida Department of Health, FL, USA
    J Urban Health 81:401-15. 2004
    ..Such estimates could be useful for behavioral surveillance and resource allocation, including enhanced targeting of community-based interventions for primary and secondary HIV prevention...
  71. ncbi Emerging future issues in HIV/AIDS social research
    Samuel R Friedman
    AIDS 20:959-65. 2006
  72. ncbi A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City
    Benny J Kottiri
    Office of HIV AIDS, US Agency for International Development, 1300 Pennsylvania Avenue, NW, Washington, DC 20523, USA
    J Urban Health 82:479-87. 2005
    ..Whereas subsequent younger generations benefited from universal childhood hepatitis B immunization, this particular cohort of young adults who live in communities like Bushwick presents a unique group for prevention intervention...
  73. ncbi The social structural production of HIV risk among injecting drug users
    Tim Rhodes
    The Centre for Research on Drugs and Health Behaviour, Imperial College London, UK
    Soc Sci Med 61:1026-44. 2005
    ....
  74. ncbi Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in a low-income minority neighborhood
    Peter L Flom
    J Infect Dis 191:818-20; author reply 820-1. 2005
  75. ncbi Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999
    Scott S Santibanez
    Division of HIV AIDS, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Drug Alcohol Depend 77:227-33. 2005
    ..We estimated prevalence and identified correlates of crack-cocaine injection among young injection drug users in the United States...
  76. ncbi The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil
    Mariana A Hacker
    Department of Health Information, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
    Subst Use Misuse 40:99-123. 2005
    ....
  77. ncbi Correlates of attempted suicide among young injection drug users in a multi-site cohort
    Jennifer R Havens
    Center on Drug and Alcohol Research, University of Kentucky, 915B South Limestone, Lexington, KY 40536, USA
    Drug Alcohol Depend 75:261-9. 2004
    ..These data suggest that increased access to drug treatment, community mental health, and violence prevention programs may decrease suicidal behavior among young injection drug users...
  78. ncbi Public health principles for the HIV epidemic
    Samuel R Friedman
    N Engl J Med 354:877-8; author reply 877-8. 2006
  79. ncbi Harnessing the power of social networks to reduce HIV risk
    Samuel R Friedman
    Focus 20:5-6. 2005

Research Grants22

  1. Staying Safe: Long-Term Injection Drug Users Who Have Avoided HIV & Hepatitis C
    Samuel Friedman; Fiscal Year: 2007
    ..abstract_text> ..
  2. COMMUNITY VULNERABILITY AND RESPONSES TO IDU-RELATED HIV
    Samuel Friedman; Fiscal Year: 2007
    ..The resulting scientific knowledge base can help develop programs and policies so as to avoid epidemics and, if needed, control them. ..
  3. Community Vulnerability and Responses to Drug-User-Related HIV/AIDS
    Samuel Friedman; Fiscal Year: 2009
    ....
  4. LOCAL CONTEXT, SOCIAL-CONTROL ACTION, AND HIV RISK
    Samuel Friedman; Fiscal Year: 2001
    ....
  5. COMMUNITY VULNERABILITY AND RESPONSES TO IDU-RELATED HIV
    Samuel Friedman; Fiscal Year: 2003
    ....
  6. Community Vulnerability and Responses to Drug-User-Related HIV/AIDS
    Samuel R Friedman; Fiscal Year: 2010
    ....